Chinese biopharma company Akeso raises $150m for antibody drug discovery
Akeso, a Chinese biopharma company engaged in antibody drug discovery and development in oncology and immunology therapeutic areas,…
Celgene, Acceleron bag Reblozyl FDA approval for anemia in beta thalassemia
Reblozyl FDA approval : Celgene and Acceleron Pharma have bagged approval from the US Food and Drug Administration…
WIRB-Copernicus acquires clinical trial consultant Waife & Associates
WIRB-Copernicus Group (WCG), a clinical services organization, said that its clinical services division has acquired Waife & Associates…
WIRB-Copernicus acquires clinical trial consultant Waife & Associates
WIRB-Copernicus Group (WCG), a clinical services organization, said that its clinical services division has acquired Waife & Associates (W&A), a provider of management consulting services for biopharma clinical research clients. Financial terms of the acquisition were not disclosed by the parties. Waife & Associates is engaged in making clinical development more efficient and productive by […]
Yuhan Pharmaceuticals to use Cyclica’s AI-driven drug discovery platform
Yuhan Pharmaceuticals has entered into a collaboration with Canadian biotechnology company Cyclica to use the latter’s artificial intelligence…
Yuhan Pharmaceuticals to use Cyclica’s AI-driven drug discovery platform
Yuhan Pharmaceuticals has entered into a collaboration with Canadian biotechnology company Cyclica to use the latter’s artificial intelligence (AI) driven integrated drug discovery platform in two separate research and development (R&D) programs in oncology. The South Korean healthcare company said that it is looking to adopt innovative technologies to boost its drug development efforts. In […]
Takeda Pharmaceutical opens €130m vaccine manufacturing plant in Germany
Takeda Pharmaceutical Company opened a new €130 million vaccine manufacturing plant in Germany at Singen to produce TAK-003,…
Amgen to take 20.5% stake in Chinese biotech company BeiGene for $2.7bn
US biopharma company Amgen has signed an all-cash deal to acquire a 20.5% stake in Chinese biotech company…
Biodesix acquires Oncimmune’s laboratory and IPN malignancy test in US
Biodesix, a lung cancer diagnostic solutions company, has acquired UK-based Oncimmune’s laboratory and incidental pulmonary nodule (IPN) malignancy…
Pandion bags $795m deal with Astellas for pancreas-targeted immunomodulators
Pandion Therapeutics has bagged a $795 million worth license and collaboration deal with Japanese pharma company Astellas Pharma…